ACTRN12619000542190Completed未知
Evaluation of the Lifeline Eclipse Project, a non-clinical support group for people who have attempted suicide to reduce future suicidality.
niversity of New England0 sites130 target enrollmentStarted: April 5, 2019Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 130
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Non-randomised trial
- Primary Purpose
- Educational / counselling / training
Eligibility Criteria
- Ages
- 18 Years to o limit (—)
- Sex
- All
Inclusion Criteria
- •Prior suicide attempt/s, over 18 years, proficient in English, ability to physically attend weekly groups
Exclusion Criteria
- •Currently suicidal
Investigators
Similar Trials
Recruiting
Not Applicable
The ‘Link onto Life’ Program: A Pilot Intervention using Dialectical Behaviour Therapy (DBT) to Enhance Coping and Wellbeing in Young People (18-24 years).ACTRN12615000943549Dr Suzanne Dziurawiec48
Completed
Not Applicable
An evaluation of the Cares of Life Project (CoLP): Fundamentally improving mental health services for Black people in SouthwarkISRCTN06101946King's College London (UK)80
Recruiting
Not Applicable
ationwide evaluation of the pilot projects for the Ü45-Check according to § 14 Abs. 3 SGB VIJob-related participation disorderDRKS00024034Deutsche Rentenversicherung Bund2,500
Completed
Unknown
Piloting and evaluation of a newly developed evidence-based intervention on skin cancer prevention to support and promote self-management in individuals after solid organ transplantatioSelf-Management, Solid Organ Transplant (Chronic Disease)Z94Transplanted organ and tissue statusDRKS00032953Institut für Pflegewissenschaft, Medizinische Fakultät, Universität Freiburg7
Completed
Phase 4
An open-label, prospective, non randomised, non comparative, multicenter, observational pharmacovigilence study of the safety and effectiveness of new treatment modalities to treat VL in public sector of India.CTRI/2012/08/002891Drugs for Neglected Diseases initiative DNDi7,000